Treatment of 5‘- O- nitro esters of nucleosides with tributylstannane and AIBN at elevated temperatures caused β-scission of the resulting 5‘-oxygen radical to give formaldehyde and dehomologated erythrofuranosyl nucleosides. Analogous treatment of 6‘- O- nitro esters of homonucleosides [(5-deoxy-β- d - ribo- hexofuranosyl)adenine or uracil nucleosides derived from d -glucose] resulted in generation of a 6‘-oxygen radical followed by abstraction of H3‘ by a [1,5]-hydrogen shift. Radical quenching with tributyltin deuteride gave 3‘-[ 2 H]homonucleosides. This deuterium transfer, and inversion of configuration at C3‘ with unprotected homonucleosides, confirmed the relay-generation of C3‘ free radicals. Analogous treatment of 6‘- O- nitro esters of homonucleosides containing a 2‘-chloro ( 30 ) or 2‘- O- tosyl ( 40 ) substituent resulted in complete disappearance of starting material and generation of ( R )-2-(2-hydroxyethyl)-3(2 H )-furanone ( 33 ). Generation of a 6‘-oxygen radical, [1,5]-hydrogen shift of H3‘ to give a C3‘ radical, and loss of the 2‘-substituent would give unstable intermediates that could lose the heterocyclic base from C1‘ to give 33 . This radical-initiated cascade simulates reactions postulated to occur at the active site of ribonucleotide reductases. Generation of a C3‘ radical from 40 and loss of toluenesulfonic acid via a [1,2]-electron shift would generate a radical intermediate that could undergo deuterium transfer followed by β-elimination of the base to give the deuterated furanone 33, as observed. This is in harmony with a new mechanism for substrate reduction of nucleotides to give 2‘-deoxy products. Generation of a C3‘ radical from 30 and loss of a chlorine atom by β-radical elimination would result in conjugate elimination of base and generation of 33 without incorporation of deuterium, as observed. Thus, one-electron elimination processes (as well as the previously postulated two-electron loss with groups from C2‘) must be considered with mechanism-based inactivators of ribonucleotide reductases. Biomimetic reactions and new mechanistic considerations are discussed.
No takes yet. Share an insight, caveat, or question.
Robins et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: